Literature DB >> 27506955

Antinociceptive action of botulinum toxin type A in carrageenan-induced mirror pain.

V Drinovac Vlah1, L Bach-Rojecky2, Z Lacković3.   

Abstract

"Mirror pain" or mirror-image pain (MP) is pain opposite to the side of injury. Mechanism and frequency in humans are not known. There is no consent on therapy. Here we report that unilaterally injected botulinum toxin type A (BT-A) has bilateral effect in experimental MP, thus deserves to be investigated as therapy for this condition. We examined the localization of BT-A's bilateral antinociceptive action in MP induced by 3 % carrageenan intramuscular injection in Wistar rats. BT-A was applied peripherally (5 U/kg), into ipsilateral or contralateral hind paw pad (i.pl.) and centrally (1 U/kg), at spinal (intrathecally, i.t.) or supraspinal (intracisternally, i.c.) level. Additionally, we examined the involvement of central opioid and GABAergic systems, as well as the contribution of peripheral capsaicin-sensitive neurons to BT-A's bilateral antinociceptive effect. Ipsilateral i.pl. and i.t. BT-A reduced the bilateral mechanical sensitivity to von Frey filaments, while contralateral i.pl. and i.c. treatments had no effect on either tested side. Bilateral antinociceptive effect of ipsilateral i.pl. BT-A was prevented by μ-opioid antagonist naloxonazine (1.5 μg/10 μl) and GABAA antagonist bicuculline (1 μg/10 μl) if applied at the spinal level, in contrast to supraspinal application of the same doses. Local treatment of sciatic nerve with 2 % capsaicin 5 days following BT-A i.pl. injection caused desensitization of sciatic capsaicin-sensitive fibers, but did not affect bilateral antinociceptive effect of BT-A and the presence of cleaved SNAP-25 at the spinal cord slices. Present experiments suggest segmental actions of peripheral BT-A at spinal level, which are probably not solely dependent on capsaicin-sensitive neurons.

Entities:  

Keywords:  Botulinum toxin A; Capsaicin-sensitive neurons; Cleaved SNAP-25; GABAA antagonist; Mirror pain; μ-opioid antagonist

Mesh:

Substances:

Year:  2016        PMID: 27506955     DOI: 10.1007/s00702-016-1605-7

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  48 in total

1.  Models of muscle pain: carrageenan model and acidic saline model.

Authors:  Rajan Radhakrishnan; Marie K Hoeger Bement; David Skyba; Kathleen A Sluka; Lois J Kehl
Journal:  Curr Protoc Pharmacol       Date:  2004-09-01

2.  Enhanced descending modulation of nociception in rats with persistent hindpaw inflammation.

Authors:  K Ren; R Dubner
Journal:  J Neurophysiol       Date:  1996-11       Impact factor: 2.714

3.  Association of antinociceptive action of botulinum toxin type A with GABA-A receptor.

Authors:  V Drinovac; L Bach-Rojecky; Z Lacković
Journal:  J Neural Transm (Vienna)       Date:  2014-01-14       Impact factor: 3.575

4.  Sensory testing in patients with postthoracotomy pain syndrome: Part 1: mirror-image sensory dysfunction.

Authors:  Mads U Werner; Thomas K Ringsted; Henrik Kehlet; Kim Wildgaard
Journal:  Clin J Pain       Date:  2013-09       Impact factor: 3.442

5.  Quantitative assessment of tactile allodynia in the rat paw.

Authors:  S R Chaplan; F W Bach; J W Pogrel; J M Chung; T L Yaksh
Journal:  J Neurosci Methods       Date:  1994-07       Impact factor: 2.390

6.  Different antinociceptive effects of botulinum toxin type A in inflammatory and peripheral polyneuropathic rat models.

Authors:  Christine Favre-Guilmard; Michel Auguet; Pierre-Etienne Chabrier
Journal:  Eur J Pharmacol       Date:  2009-07-01       Impact factor: 4.432

7.  Stimulation of deep somatic tissue with capsaicin produces long-lasting mechanical allodynia and heat hypoalgesia that depends on early activation of the cAMP pathway.

Authors:  K A Sluka
Journal:  J Neurosci       Date:  2002-07-01       Impact factor: 6.167

8.  ASICs Do Not Play a Role in Maintaining Hyperalgesia Induced by Repeated Intramuscular Acid Injections.

Authors:  Mamta Gautam; Christopher J Benson; Jon D Ranier; Alan R Light; Kathleen A Sluka
Journal:  Pain Res Treat       Date:  2011-12-08

9.  Bilateral sensory abnormalities in patients with unilateral neuropathic pain; a quantitative sensory testing (QST) study.

Authors:  Karl-Heinz Konopka; Marten Harbers; Andrea Houghton; Rudie Kortekaas; Andre van Vliet; Wia Timmerman; Johan A den Boer; Michel M R F Struys; Marten van Wijhe
Journal:  PLoS One       Date:  2012-05-22       Impact factor: 3.240

10.  Interaction of hyperalgesia and sensory loss in complex regional pain syndrome type I (CRPS I).

Authors:  Volker Huge; Meike Lauchart; Stefanie Förderreuther; Wibke Kaufhold; Michael Valet; Shahnaz Christina Azad; Antje Beyer; Walter Magerl
Journal:  PLoS One       Date:  2008-07-23       Impact factor: 3.240

View more
  5 in total

Review 1.  Botulinum toxin type A in motor nervous system: unexplained observations and new challenges.

Authors:  I Matak; Z Lacković; M Relja
Journal:  J Neural Transm (Vienna)       Date:  2016-09-01       Impact factor: 3.575

Review 2.  [Modern non-cosmetic treatment with botulinum toxins].

Authors:  A Straube
Journal:  Internist (Berl)       Date:  2017-12       Impact factor: 0.743

Review 3.  Botulinum Neurotoxins in Central Nervous System: An Overview from Animal Models to Human Therapy.

Authors:  Siro Luvisetto
Journal:  Toxins (Basel)       Date:  2021-10-22       Impact factor: 4.546

Review 4.  Mechanisms of Botulinum Toxin Type A Action on Pain.

Authors:  Ivica Matak; Kata Bölcskei; Lidija Bach-Rojecky; Zsuzsanna Helyes
Journal:  Toxins (Basel)       Date:  2019-08-05       Impact factor: 4.546

5.  Direct Inhibition of Microglia Activation by Pretreatment With Botulinum Neurotoxin A for the Prevention of Neuropathic Pain.

Authors:  Xiaona Feng; Donglin Xiong; Jie Li; Lizu Xiao; Weijiao Xie; Yunhai Qiu
Journal:  Front Neurosci       Date:  2021-12-07       Impact factor: 4.677

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.